privatizing the delivery of Medicaid drug benefits on drug spending. Exploiting granular data that allow us to examine drug … utilization, we find that drug spending would fall by 22.4 percent if the drug benefit was fully administered by Medicaid Managed …

prescription psychotropic medication use. We examine the effect of state-level Medicaid expansion following the 2014 implementation …

study the effects of recent and major eligibility expansions within Medicaid, a public insurance system for the poor in the … administrative data on medications for which Medicaid was a third-party payer over the period 2011 to 2017. Our findings suggest that … these expansions increased psychotropic prescriptions by 22.3%. We show that Medicaid, and not patients, financed these …

implications for regulation and welfare. We address endogeneity issues by demonstrating that patients with higher disease severity …

evidence of how this relationship varies across markets. We investigate whether recent expansions in state Medicaid programs … caused an increase in R&D. We find no evidence of a response, potentially a result of Medicaid's low reimbursement for …